- Home
- AGD vs ABEO Comparison
AGD vs ABEO Comparison
Compare AGD & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGD
- ABEO
- Stock Information
- Founded
- AGD 2006
- ABEO 1974
- Country
- AGD United Kingdom
- ABEO United States
- Employees
- AGD N/A
- ABEO N/A
- Industry
- AGD Trusts Except Educational Religious and Charitable
- ABEO Biotechnology: Pharmaceutical Preparations
- Sector
- AGD Finance
- ABEO Health Care
- Exchange
- AGD Nasdaq
- ABEO Nasdaq
- Market Cap
- AGD 263.6M
- ABEO 256.9M
- IPO Year
- AGD N/A
- ABEO 1980
- Fundamental
- Price
- AGD $11.10
- ABEO $5.57
- Analyst Decision
- AGD
- ABEO Strong Buy
- Analyst Count
- AGD 0
- ABEO 6
- Target Price
- AGD N/A
- ABEO $18.00
- AVG Volume (30 Days)
- AGD 61.2K
- ABEO 1.1M
- Earning Date
- AGD 01-01-0001
- ABEO 08-11-2025
- Dividend Yield
- AGD 8.13%
- ABEO N/A
- EPS Growth
- AGD N/A
- ABEO N/A
- EPS
- AGD N/A
- ABEO N/A
- Revenue
- AGD N/A
- ABEO N/A
- Revenue This Year
- AGD N/A
- ABEO N/A
- Revenue Next Year
- AGD N/A
- ABEO $323.51
- P/E Ratio
- AGD N/A
- ABEO N/A
- Revenue Growth
- AGD N/A
- ABEO N/A
- 52 Week Low
- AGD $8.20
- ABEO $3.93
- 52 Week High
- AGD $9.78
- ABEO $7.32
- Technical
- Relative Strength Index (RSI)
- AGD 74.74
- ABEO 37.51
- Support Level
- AGD $10.34
- ABEO $5.66
- Resistance Level
- AGD $11.04
- ABEO $6.24
- Average True Range (ATR)
- AGD 0.11
- ABEO 0.26
- MACD
- AGD 0.04
- ABEO -0.08
- Stochastic Oscillator
- AGD 100.00
- ABEO 8.08
About AGD abrdn Global Dynamic Dividend Fund of Beneficial Interest
Aberdeen Global Dynamic Dividend Fund is a diversified, closed-end management investment company. The fund's primary investment objective is to seek high current dividend income, more than 50% of which qualifies for the reduced federal income tax rate, as created by the Jobs and Growth Tax Relief Reconciliation Act of 2003. The fund also focuses on the long-term growth of capital as a secondary investment objective. The fund's portfolio holdings are in information technology, financials, health care, and consumer discretionary sectors among others.
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.